PL434248A1 - Staphylococcus aureus strain for the production of monoclonal phage preparations deprived of impurities by plasmid DNA - Google Patents

Staphylococcus aureus strain for the production of monoclonal phage preparations deprived of impurities by plasmid DNA

Info

Publication number
PL434248A1
PL434248A1 PL434248A PL43424814A PL434248A1 PL 434248 A1 PL434248 A1 PL 434248A1 PL 434248 A PL434248 A PL 434248A PL 43424814 A PL43424814 A PL 43424814A PL 434248 A1 PL434248 A1 PL 434248A1
Authority
PL
Poland
Prior art keywords
production
plasmid dna
staphylococcus aureus
deprived
impurities
Prior art date
Application number
PL434248A
Other languages
Polish (pl)
Other versions
PL236569B1 (en
Inventor
Małgorzata ŁOBOCKA
Monika HEJNOWICZ
Kamil DĄBROWSKI
Dariusz IZAK
Agnieszka GOZDEK
Jan GAWOR
Jarosław KOSAKOWSKI
Robert GROMADKA
Beata WEBER-DĄBROWSKA
Andrzej Górski
Original Assignee
Instytut Biochemii I Biofizyki Polskiej Akademii Nauk
Instytut Immunologii I Terapii Doświadczalnej Polskiej Akademii Nauk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Instytut Biochemii I Biofizyki Polskiej Akademii Nauk, Instytut Immunologii I Terapii Doświadczalnej Polskiej Akademii Nauk filed Critical Instytut Biochemii I Biofizyki Polskiej Akademii Nauk
Priority to PL434248A priority Critical patent/PL236569B1/en
Publication of PL434248A1 publication Critical patent/PL434248A1/en
Publication of PL236569B1 publication Critical patent/PL236569B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/00051—Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Ujawniono szczep Staphylococcus aureus do otrzymywania monoklonalnych preparatów bakteriofagów litycznych o wysokim mianie, pozbawionych zanieczyszczeń niepożądanymi bakteriofagami oraz plazmidowym DNA, który gwarantuje produkcję bezpiecznych w stosowaniu preparatów bakteriofagowych nie będących źródłem rozsiewu genów związanych z wirulencją bakterii.The Staphylococcus aureus strain was disclosed for the production of monoclonal preparations of lytic bacteriophages with high titer, free from contamination with unwanted bacteriophages and plasmid DNA, which guarantees the production of safe to use bacteriophage preparations that are not a source of genes related to bacterial virulence.

PL434248A 2014-08-31 2014-08-31 Staphylococcus aureus strain for the production of monoclonal phage preparations deprived of impurities by plasmid DNA PL236569B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL434248A PL236569B1 (en) 2014-08-31 2014-08-31 Staphylococcus aureus strain for the production of monoclonal phage preparations deprived of impurities by plasmid DNA

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL434248A PL236569B1 (en) 2014-08-31 2014-08-31 Staphylococcus aureus strain for the production of monoclonal phage preparations deprived of impurities by plasmid DNA

Publications (2)

Publication Number Publication Date
PL434248A1 true PL434248A1 (en) 2020-10-05
PL236569B1 PL236569B1 (en) 2021-01-25

Family

ID=72669373

Family Applications (1)

Application Number Title Priority Date Filing Date
PL434248A PL236569B1 (en) 2014-08-31 2014-08-31 Staphylococcus aureus strain for the production of monoclonal phage preparations deprived of impurities by plasmid DNA

Country Status (1)

Country Link
PL (1) PL236569B1 (en)

Also Published As

Publication number Publication date
PL236569B1 (en) 2021-01-25

Similar Documents

Publication Publication Date Title
HUE036362T2 (en) Preparations containing bacterial strains
HUE041969T2 (en) Preparations containing bacterial strains
HUE046221T2 (en) Preparations containing bacterial strains
HUE058252T2 (en) Preparations containing bacterial strains
HUE046681T2 (en) Preparations containing bacterial strains
HUE059249T2 (en) Preparations containing bacterial strains
PH12016502555A1 (en) Methods of preparing substituted nucleotide analogs
WO2015153889A3 (en) Materials and methods for the treatment of latent viral infection
MX2022000056A (en) Stabilized anti-microbial peptides.
MX2017008184A (en) Substituted nucleosides, nucleotides and analogs thereof.
DK3400290T3 (en) Oncolytic virus strain
PH12017500858A1 (en) Mocrocyclic peptides useful as immunomodulators
DK3377082T3 (en) COMPOSITIONS INCLUDING BACTERIA STRAINS
LT3307288T (en) COMPOSITIONS INCLUDING BACTERIAL STRAINS
LT3137497T (en) AAV VECTORS FOR NETWORK AND CNS GENE THERAPY
MX389684B (en) ANTI-TIGIT ANTIBODIES.
HK1245326A1 (en) Compositions and methods for the production of scaav
EA201790265A1 (en) METHODS FOR OBTAINING PLATELET-CONTAINING PRODUCTS
IL251178A0 (en) Adeno-associated viral vector for the treatment of glaucoma myocilin (myoc)
MX380393B (en) ATTENUATED INFLUENZA VECTORS FOR THE PREVENTION AND/OR TREATMENT OF INFECTIOUS DISEASES AND FOR THE TREATMENT OF ONCOLOGICAL DISEASES.
HUE053488T2 (en) Preparations containing bacterial strains
MX2020013096A (en) Semisynthetic routes to organic compounds.
HUE052319T2 (en) Preparations containing bacterial strains
EP3403094A4 (en) BILBIOTHÈQUE OF LIGAND ADDITION PRODUCTS OF TRANSFER RNA
MX2018005872A (en) Nucleic acid prodrugs.